American Express
AXP
$320.71
-0.34%
American Express is a global financial services corporation that provides charge and credit card products, merchant payment processing, and related services to consumers and businesses across roughly 130 countries. It operates through four segments: US Consumer Services, US Commercial Services, International Card Services, and Global Merchant and Network Services, distinguishing itself as a vertically integrated payments network with a premium, affluent customer base. The current investor narrative centers on the company's ability to sustain double-digit revenue growth and margin expansion amid a volatile macroeconomic environment, with recent quarterly results showing strong fee revenue growth and raised guidance, though the stock has faced pressure from broader market selloffs and concerns about consumer credit quality.…
AXP
American Express
$320.71
Related headlines
Investment Opinion: Should I buy AXP Today?
Based on the data, AXP is rated a Buy. The consensus recommendation is 'buy' with an average target price of $375.96, implying a 15.3% upside. The thesis is that AXP's premium brand, double-digit revenue growth, and discounted forward PE (16.22x vs historical 18x) offer a favorable risk-reward. The company's strong fee income growth of 15% and raised guidance support continued earnings expansion, with estimated EPS of $29.32 for the next fiscal year.
Sign up to view all
AXP 12-Month Price Forecast
The AI model assesses AXP as a bullish opportunity with medium confidence. The company's strong revenue growth, high profitability, and discounted forward valuation provide a solid foundation. However, the stock's underperformance relative to the market and high debt levels introduce uncertainty. The model would upgrade to high confidence if revenue growth accelerates above 12% and credit metrics remain stable. Conversely, a downgrade to neutral would occur if revenue growth falls below 8% or if the forward PE expands above 20x without corresponding earnings growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American Express's 12-month outlook, with a consensus price target around $375.96 and implied upside of +17.2% versus the current price.
Average Target
$375.96
0 analysts
Implied Upside
+17.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$315 - $450
Analyst target range
The target price range spans from a low of $315.00 to a high of $450.00, with the high target representing a 38% upside from current levels, likely assuming continued strong growth and multiple expansion. The low target is slightly below the current price, suggesting some analysts see downside risk if credit quality deteriorates or growth slows. The wide spread between the low and high targets (approximately 43% of the average target) indicates significant uncertainty about the company's future performance, which is typical for a financial services company sensitive to economic cycles. Recent institutional ratings show a mix of upgrades and holds, with no major downgrades, suggesting that sentiment is cautiously optimistic but not overly enthusiastic.
Bulls vs Bears: AXP Investment Factors
AXP presents a balanced but slightly bullish case. The company's double-digit revenue growth, strong fee income, and discounted forward PE provide solid fundamental support. However, the stock's underperformance relative to the S&P 500 and high debt levels introduce meaningful risks. The most important tension is whether the market's skepticism about consumer credit quality and growth sustainability is justified. If AXP continues to deliver 10%+ revenue growth and maintains credit metrics, the stock could re-rate higher toward the average target of $376. Conversely, any sign of deteriorating credit or spending slowdown could push the stock toward the low target of $315. Currently, the evidence slightly favors the bulls given the valuation discount and analyst consensus, but the risk-reward is not overwhelmingly skewed.
Bullish
- Double-digit revenue growth continues: Q1 2026 revenue grew 10.28% YoY to $20.88B, with sequential growth from $19.93B in Q2 2025 and $20.54B in Q3 2025. This steady trajectory shows the premium consumer base remains resilient, supporting fee income growth of 15% in Q2 2026.
- Forward PE at discount to history: The forward PE of 16.22x is below the 5-year historical average of ~18x, suggesting the market is pricing in lower growth than the company has historically delivered. This valuation gap provides a margin of safety if growth persists.
- Strong profitability and cash flow: Net margin is 13.46%, ROE is 32.36%, and free cash flow TTM is $14.32B. These metrics indicate a highly efficient business model that generates substantial cash to support dividends and buybacks.
- Analyst consensus is Buy with upside: With 25 analysts, the average target price is $375.96, representing ~15.3% upside from the current price of $326.16. The high target of $450 implies 38% upside, reflecting confidence in the company's growth runway.
Bearish
- Significant underperformance vs S&P 500: AXP is down 1.36% over the past year while the S&P 500 gained 18.65%, a relative underperformance of ~20 percentage points. This suggests persistent negative sentiment or sector-specific headwinds that could continue.
- High debt-to-equity ratio: Debt-to-equity stands at 1.73x, reflecting the capital-intensive nature of the lending business. Elevated leverage increases vulnerability to credit cycle downturns and rising funding costs.
- Credit quality concerns loom: With a beta of 1.048, AXP is sensitive to economic cycles. Rising consumer delinquencies or a recession could pressure loan loss provisions, directly impacting earnings. The low analyst target of $315 is below the current price, signaling downside risk.
- Valuation premium on trailing earnings: The trailing PE of 24.01x is above the 5-year average of ~18x, implying the market already expects strong growth. If growth decelerates, the stock could face multiple compression, as seen in the recent 6.5% drop on a slight revenue miss.
AXP Technical Analysis
American Express is currently in a consolidation phase within a broader uptrend, as the stock trades at $326.16, which is approximately 84% of its 52-week range (between $290.97 low and $387.49 high). Over the past year, the stock has declined 1.36%, significantly underperforming the S&P 500's gain of 18.65%, indicating relative weakness. The price is well off its 52-week high of $387.49, suggesting that the stock has retraced from its peak and is now trading in the lower half of its yearly range, which could signal a potential value opportunity if fundamentals remain intact.
Beta
1.05
1.05x market volatility
Max Drawdown
-24.1%
Largest decline past year
52-Week Range
$291-$387
Price range past year
Annual Return
-0.8%
Cumulative gain past year
| Period | AXP Return | S&P 500 |
|---|---|---|
| 1m | -5.9% | -1.6% |
| 3m | -1.5% | +2.2% |
| 6m | +6.9% | +14.4% |
| 1y | -0.8% | +16.2% |
| ytd | -14.0% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXP Fundamental Analysis
American Express reported revenue of $20.88 billion for Q1 2026, representing a 10.28% year-over-year increase, with sequential growth from $19.93 billion in Q2 2025 and $20.54 billion in Q3 2025, indicating a steady upward trajectory. The company's revenue growth is being driven by strong fee income, which grew 15% in Q2 2026, and robust spending by its premium consumer base, as evidenced by the 10%+ growth in card member spending. However, the growth rate has moderated from the 15%+ levels seen in 2024, reflecting a normalization in consumer spending patterns.
Quarterly Revenue
$20.9B
2026-03
Revenue YoY Growth
+10.3%
YoY Comparison
Gross Margin
84.6%
Latest Quarter
Free Cash Flow
$14.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXP Overvalued?
Given that American Express has positive net income, the PE ratio is the primary valuation metric. The trailing PE stands at 24.01x, while the forward PE is 16.22x, implying that the market expects significant earnings growth over the next year. This gap between trailing and forward PE suggests that analysts anticipate a substantial increase in EPS, which is consistent with the consensus EPS estimate of $29.32 for the next fiscal year. The forward PE of 16.22x is below the 5-year historical average PE of approximately 18x, indicating that the stock is trading at a discount to its own historical valuation.
PE
24.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are notable. AXP's debt-to-equity ratio of 1.73x indicates significant leverage, which amplifies the impact of rising interest rates on net interest income and credit costs. The company's net income margin of 13.46% is healthy, but any increase in loan loss provisions could compress it. Revenue concentration in premium consumer spending makes earnings sensitive to economic downturns, as evidenced by the 6.5% stock drop on a slight revenue miss in July 2026. Free cash flow of $14.32B provides a cushion, but the high payout ratio of 20.96% and ongoing buybacks could strain liquidity if cash flows decline.
FAQ
The key risks include: 1) Financial risk from high debt-to-equity of 1.73x, which could strain earnings if interest rates rise or credit losses increase. 2) Market risk from the stock's beta of 1.048, making it more volatile than the market, and its underperformance vs the S&P 500. 3) Competitive risk from fintechs like Affirm and traditional banks that could erode market share. 4) Macro risk from a recession, which would reduce consumer spending and increase credit costs. The most severe risk is a credit cycle downturn, which could push the stock to its 52-week low of $290.97.
The 12-month forecast is moderately bullish. The base case (50% probability) sees the stock trading around $375.96, the average analyst target, implying a 15.3% upside. The bull case (30% probability) targets $380-$450, driven by strong growth and multiple expansion. The bear case (20% probability) sees the stock falling to $290-$315 if credit deteriorates. The most likely scenario is the base case, assuming revenue growth of 8-10% and stable credit. Investors should monitor quarterly earnings and credit metrics to gauge which scenario is unfolding.
AXP is currently undervalued relative to its own history. The forward PE of 16.22x is below the 5-year average of ~18x, and the trailing PE of 24.01x is elevated due to lower trailing earnings. The PEG ratio of 2.46 suggests the stock is not expensive given its growth rate. Compared to peers, AXP's valuation is reasonable, as it trades at a discount to its historical multiple. The market is pricing in moderate growth, but if AXP delivers on its EPS estimate of $29.32, the stock could re-rate higher. Overall, the valuation offers a margin of safety.
AXP is a good buy for investors with a moderate risk tolerance and a long-term horizon. The stock offers a 15.3% upside to the average analyst target of $375.96, and the forward PE of 16.22x is below its historical average, suggesting undervaluation. However, the stock has underperformed the market over the past year, and there are risks from high debt levels and potential credit deterioration. For those who believe in the resilience of the premium consumer, AXP is a compelling buy; for those concerned about a recession, it may be better to wait for a pullback toward $300.
AXP is better suited for long-term investment due to its stable business model, strong brand, and consistent growth. The stock's beta of 1.048 indicates moderate volatility, making it less ideal for short-term trading. The dividend yield of 0.88% provides a small income component, and the company's high ROE of 32.36% suggests efficient capital deployment. For long-term investors, a minimum holding period of 3-5 years is recommended to ride out economic cycles and benefit from earnings growth. Short-term traders may find opportunities around earnings announcements, but the stock's relative weakness suggests patience is needed.